{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:43:47Z","timestamp":1789695827741,"version":"4.0.1"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"CONCAWE; European Oil Company Organisation for Environment, Health and Safety"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.tox.2016.01.008","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T13:31:32Z","timestamp":1453728692000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Oral exposure to mineral oils: Is there an association with immune perturbation and autoimmunity?"],"prefix":"10.1016","volume":"344-346","author":[{"given":"Ian","family":"Kimber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2016.01.008_bib0005","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/0961203311429316","article-title":"The spectrum of ASIA: \u2018autoimmune (autoinflammatory) syndrome-induced by adjuvants\u2019","volume":"21","author":"Agmon-Levin","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.tox.2016.01.008_bib0010","first-page":"1086","article-title":"Induction of plasma-cell neoplasms in strain BALB\/c mice with mineral oil and mineral oil adjuvants","volume":"193","author":"Anderson","year":"1969","journal-title":"Nature (Lond.)"},{"key":"10.1016\/j.tox.2016.01.008_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/10643380390814460","article-title":"Composition and analysis of mineral oils and other organic compounds in metalworking and hydraulic fluids","volume":"33","author":"Anderson","year":"2003","journal-title":"Crit. Rev. Env. Sci. Tech."},{"key":"10.1016\/j.tox.2016.01.008_bib0020","first-page":"251","article-title":"Alum, an aluminium-based adjuvant, induces Sjogren\u2019s syndrome-like disorder in mice","volume":"32","author":"Bagavant","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.tox.2016.01.008_bib0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/019262339202000312","article-title":"Feeding studies in rats with mineral hydrocarbon food grade white oils","volume":"20","author":"Baldwin","year":"1992","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2016.01.008_bib0030","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00217-011-1478-9","article-title":"Removal of mineral oil migrated from paperboard packing during cooking of foods in boiling water","volume":"232","author":"Biedermann-Brem","year":"2011","journal-title":"Eur. Food Res. Technol."},{"key":"10.1016\/j.tox.2016.01.008_bib0035","unstructured":"Burleson, G.R., 2001. Unpublished study conducted by Burleson Research Technologies, Raleigh, North Carolina, USA for the American Petroleum Institute, Washington DC, USA. Cited in WHO\/IPCS 2003."},{"key":"10.1016\/j.tox.2016.01.008_bib0040","first-page":"257","article-title":"Clinical, histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils","volume":"46","author":"Cabral","year":"1994","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.tox.2016.01.008_bib0045","first-page":"7","article-title":"Induction of arthritis in DA rats by incomplete Freund\u2019s adjuvant","volume":"20","author":"Cannon","year":"1993","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.tox.2016.01.008_bib0050","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0002-9440(10)65077-8","article-title":"The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats","volume":"156","author":"Carlson","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2016.01.008_bib0055","first-page":"247","article-title":"Assessment of the morphology and significance of the lymph nodal and hepatic lesions produced in rats by the feeding of certain mineral oils and waxes","volume":"53","author":"Carlton","year":"2001","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tox.2016.01.008_bib0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/02652039309374141","article-title":"Migration of mineral hydrocarbons into foods. 3. Cheese coatings and temporary casings for skinless sausages","volume":"10","author":"Castle","year":"1993","journal-title":"Food Addit. Contam."},{"key":"10.1016\/j.tox.2016.01.008_bib0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants\u2014a classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2016.01.008_bib0070","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/eji.200838648","article-title":"Alum adjuvanticity: unravelling a century old mystery","volume":"38","author":"De Gregorio","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0075","first-page":"2074","article-title":"Scientific opinion on mineral oil hydrocarbons in food","volume":"10","author":"EFSA (European Food Standards Agency)","year":"2012","journal-title":"EFSA J."},{"key":"10.1016\/j.tox.2016.01.008_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00431","article-title":"Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity","volume":"5","author":"Eshleman","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/019262339502300104","article-title":"Comparative 90-day feeding study with low-viscosity white mineral oil in Fischer-344 and Sprague-Dawley-derived CRL:CD rats","volume":"23","author":"Firriolo","year":"1995","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2016.01.008_bib0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nm.2306","article-title":"Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity","volume":"17","author":"Flach","year":"2011","journal-title":"Nature Med."},{"key":"10.1016\/j.tox.2016.01.008_bib0095","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","article-title":"Mucosal adjuvants","volume":"23","author":"Freytag","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2016.01.008_bib0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/02652039709374500","article-title":"Mineral oil material in canned foods","volume":"14","author":"Grob","year":"1997","journal-title":"Food Addit. Contam."},{"key":"10.1016\/j.tox.2016.01.008_bib0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants\u2014a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2016.01.008_bib0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","article-title":"Type I interferons: crucial participants in disease amplification in autoimmunity","volume":"6","author":"Hall","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.tox.2016.01.008_bib0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1191\/096032700678827726","article-title":"Short-term adverse effects in humans of ingested mineral oils, their additives and possible contaminants\u2014a review","volume":"19","author":"Hard","year":"2000","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2016.01.008_bib0120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0278-6915(02)00063-7","article-title":"Dietary exposures to mineral hydrocarbons from food-use applications in the United States","volume":"40","author":"Heimbach","year":"2002","journal-title":"Food. Chem. Toxicol."},{"key":"10.1016\/j.tox.2016.01.008_bib0125","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.4049\/jimmunol.179.11.7568","article-title":"The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis","volume":"179","author":"Hoffmann","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0130","first-page":"176","article-title":"Alteration of Kupffer cell function and morphology by low melt point paraffin wax in female Fischer-344 but not in Sprague-Dawley rats","volume":"46","author":"Hoglen","year":"1998","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.01.008_bib0135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1365-2249.2002.01783.x","article-title":"The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes","volume":"127","author":"Holm","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1034\/j.1600-065x.2001.1840117.x","article-title":"Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis","volume":"184","author":"Holmdahl","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tox.2016.01.008_bib0145","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1289\/ehp.10846","article-title":"The role of exposure to phthalates from polyvinyl chloride products in the development of asthma and allergies: a systematic review and meta-analysis","volume":"116","author":"Jaakkola","year":"2008","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2016.01.008_bib0150","doi-asserted-by":"crossref","DOI":"10.1186\/ar4435","article-title":"MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats","author":"Jiang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.tox.2016.01.008_bib0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tox.2010.03.020","article-title":"An assessment of the ability of phthalates to influence immune and allergic responses","volume":"271","author":"Kimber","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2016.01.008_bib0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1586\/14760584.2.2.305","article-title":"CpG DNA as a vaccine adjuvant","volume":"2","author":"Klinman","year":"2003","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.tox.2016.01.008_bib0165","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells","volume":"205","author":"Kool","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tox.2016.01.008_bib0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2567.2009.03164.x","article-title":"T-helper 1 and T h-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection","volume":"129","author":"Korsholm","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.tox.2016.01.008_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780270101","article-title":"Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on 18 patients and a review of the Japanese literature","volume":"27","author":"Kumagai","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tox.2016.01.008_bib0180","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/toxsci\/kfh063","article-title":"Distinctive patterns of autoimmune response induced by different types of mineral oil","volume":"78","author":"Kuroda","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.01.008_bib0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.biopha.2004.04.009","article-title":"Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine","volume":"58","author":"Kuroda","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tox.2016.01.008_bib0190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tox.2005.10.011","article-title":"Induction of lupus related specific autoantibodies by non-specific inflammation caused by an intraperitoneal injection of n-hexadecane in BALB\/c mice","volume":"218","author":"Kuroda","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2016.01.008_bib0195","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1002\/art.30573","article-title":"CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis","volume":"63","author":"Laragione","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tox.2016.01.008_bib0200","first-page":"221","article-title":"Response of the peritoneal mesothelium to the mineral oil, pristane","volume":"122","author":"Leak","year":"1985","journal-title":"Curr. Topics Microbiol. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0205","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1084\/jem.20080462","article-title":"TLR7-dependent and Fc\u03b3R-independent production of type I interferon in experimental mouse lupus","volume":"205","author":"Lee","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tox.2016.01.008_bib0210","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.4049\/jimmunol.180.7.5101","article-title":"A novel type I IFN-producing cell subset in murine lupus","volume":"180","author":"Lee","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0215","first-page":"1","article-title":"Normal paraffins in living matter\u2014occurrence, metaboloism and pathology","volume":"3","author":"Lester","year":"1979","journal-title":"Prog. Food Nutr. Sci."},{"key":"10.1016\/j.tox.2016.01.008_bib0220","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants\u2014in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2016.01.008_bib0225","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/10473220390237467","article-title":"Petroleum mineral oil refining and evaluation of cancer hazard","volume":"18","author":"Mackerer","year":"2003","journal-title":"Appl. Occup. Environ. Hyg."},{"key":"10.1016\/j.tox.2016.01.008_bib0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/rtph.1996.0009","article-title":"Variable responses of species and strains to white mineral oils and paraffin waxes","volume":"23","author":"Miller","year":"1996","journal-title":"Reg. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2016.01.008_bib0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","article-title":"Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop","volume":"39","author":"Miller","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.tox.2016.01.008_bib0240","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaut.2012.05.001","article-title":"Criteria for environmentally associated autoimmune diseases","volume":"39","author":"Miller","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.tox.2016.01.008_bib0245","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.tibs.2009.06.011","article-title":"Activating immunity: lessons from the TLRs and NLRs","volume":"34","author":"Monie","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tox.2016.01.008_bib0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.berh.2012.01.010","article-title":"The role of environmental factors in the pathogenesis of non-organ-specific autoimmune diseases","volume":"26","author":"Muniz Caldos","year":"2012","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.tox.2016.01.008_bib0255","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2353\/ajpath.2006.050125","article-title":"Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane)","volume":"168","author":"Nacionales","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2016.01.008_bib0260","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.23023","article-title":"Deficiency of the type I interferon receptor protects mice from experimental lupus","volume":"56","author":"Nacionales","year":"2008","journal-title":"Arthritis Rhem."},{"key":"10.1016\/j.tox.2016.01.008_bib0265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0278-6915(95)00106-9","article-title":"A toxicological review of topical exposure to white mineral oils","volume":"34","author":"Nash","year":"1996","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tox.2016.01.008_bib0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clim.2014.06.007","article-title":"Serum antibodies in pristane-induced lupus are regulated by neutrophil gelatinase associated lipocalin","volume":"154","author":"Pawar","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0275","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.tox.2016.01.008_bib0280","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.4049\/jimmunol.127.4.1591","article-title":"Genetics of susceptibility to pristane-induced plasmacytomas in BALB\/cAn: reduced susceptibility in BALB\/cJ with a brief description of pristane-induced arthritis","volume":"127","author":"Potter","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0285","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/02772249909358721","article-title":"Compilation of EINECS: descriptions an definitions used for UVCB substances: complex reaction products, plant products, (post-reacted) naturally occurring substances, micro-organisms, petroleum products, soaps and detergens, and metallic compounds","volume":"69","author":"Rasmussen","year":"1999","journal-title":"Toxicol. Environ. Chem."},{"key":"10.1016\/j.tox.2016.01.008_bib0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants or vaccine development","volume":"30","author":"Reed","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0295","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","article-title":"Induction of autoimmunity by pristane and other naturally occurring hydrocarbons","volume":"30","author":"Reeves","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0300","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.188.5.985","article-title":"Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus","volume":"188","author":"Richards","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tox.2016.01.008_bib0305","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1084\/jem.180.6.2341","article-title":"Induction of lupus-associated autoantibodies in BLAB\/c mice by intraperitoneal injection of pristane","volume":"180","author":"Satoh","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tox.2016.01.008_bib0310","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1073\/pnas.92.24.10934","article-title":"Anti-nuclear antibody production and immune complex glomerulonephritis in BALB\/c mice treated with pristane","volume":"92","author":"Satoh","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2016.01.008_bib0315","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.4049\/jimmunol.157.7.3200","article-title":"Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane","volume":"157","author":"Satoh","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0320","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2249.2000.01276.x","article-title":"Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane","volume":"121","author":"Satoh","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0896-8411(03)00083-0","article-title":"Induction of lupus autoantibodies by adjuvants","volume":"21","author":"Satoh","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.tox.2016.01.008_bib0330","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/art.23407","article-title":"Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis","volume":"58","author":"Savarese","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tox.2016.01.008_bib0335","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0952-7915(00)00120-5","article-title":"Immunologic concepts of vaccine adjuvant activity","volume":"12","author":"Schijns","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0340","first-page":"723","article-title":"Immunopathogenesis of environmentally induced lupus in mice","volume":"107","author":"Shaheen","year":"1999","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2016.01.008_bib0345","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/imt.14.81","article-title":"Are there negative CNS impacts of aluminium adjuvants used in vaccines and immunotherapy?","volume":"6","author":"Shaw","year":"2014","journal-title":"J. Immunother."},{"key":"10.1016\/j.tox.2016.01.008_bib0350","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019\u2014autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J. Autoimmune."},{"key":"10.1016\/j.tox.2016.01.008_bib0355","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1517\/17425247.4.4.323","article-title":"Oral vaccination: where are we?","volume":"4","author":"Silin","year":"2007","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.tox.2016.01.008_bib0360","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/01480549509017859","article-title":"Subchronic feeding study of four white mineral oils in dogs and rats","volume":"18","author":"Smith","year":"1995","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tox.2016.01.008_bib0365","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/019262339602400210","article-title":"Ninety-day feeding studyin Fischer-344 rats of highly refined petroleum-derived food-grade white oils and waxes","volume":"24","author":"Smith","year":"1996","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2016.01.008_bib0370","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaut.2010.05.004","article-title":"TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy","volume":"35","author":"Summers","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.tox.2016.01.008_bib0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1289\/ehp.9810627","article-title":"Common commercial cosmetic products induce arthritis in the DA rat","volume":"106","author":"Sverdrup","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2016.01.008_bib0380","doi-asserted-by":"crossref","first-page":"R1296","DOI":"10.1186\/ar1824","article-title":"Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study","volume":"7","author":"Sverdrup","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.tox.2016.01.008_bib0385","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/art.37914","article-title":"Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus","volume":"65","author":"Urbonaviciute","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tox.2016.01.008_bib0390","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1586\/eci.13.2","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld\u2019s syndrome): clinical and immunological spectrum","volume":"9","author":"Vera-Lastra","year":"2013","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0395","article-title":"Squalene-based adjuvants in vaccines","author":"WHO (World Health Organisation)","year":"2008","journal-title":"Global Vaccine Safety"},{"key":"10.1016\/j.tox.2016.01.008_bib0400","unstructured":"WHO\/IPCS (World Health Organisation\/International Programme on Chemical Safety), 2003. Safety Evaluation of Certain Food Additives Series 50, Mineral oils (medium- and low-viscosity) and paraffin waxes."},{"key":"10.1016\/j.tox.2016.01.008_bib0405","first-page":"283","article-title":"Mineral oil lipogranulomata in liver and spleen: a study of 465 autopsies","volume":"109","author":"Wanless","year":"1985","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.tox.2016.01.008_bib0410","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4161\/hv.5.6.8175","article-title":"Potential adjuvantic properties of innate immune stimuli","volume":"5","author":"Warshakoon","year":"2009","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.tox.2016.01.008_bib0415","first-page":"311","article-title":"Freund\u2019s adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition","volume":"27","author":"Whitehouse","year":"1974","journal-title":"Immunology"},{"key":"10.1016\/j.tox.2016.01.008_bib0420","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0961203311429818","article-title":"Oily adjuvants and autoimmunity: now time for reconsideration?","volume":"21","author":"Whitehouse","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.tox.2016.01.008_bib0425","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/anr.1780320812","article-title":"Pristane-induced arthritis: the immunologic and genetic features of an experimental murine model of autoimmune disease","volume":"32","author":"Wooley","year":"1989","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tox.2016.01.008_bib0430","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.4049\/jimmunol.1103113","article-title":"Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus","volume":"188","author":"Xu","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0435","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1081-1206(10)61716-4","article-title":"Cellular immunodeficiency and autoimmunity in long-termmineral oil administration","volume":"92","author":"Yel","year":"2004","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.tox.2016.01.008_bib0440","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11882-014-0465-1","article-title":"Allergic sensitization and the environment: latest update","volume":"14","author":"Yoo","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.tox.2016.01.008_bib0445","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1007\/s11033-011-1141-3","article-title":"Induction of toll-like receptor 2 positive antigen-presenting cells in spleen of pristane-induced arthritis in rats","volume":"39","author":"Zhu","year":"2012","journal-title":"Mol. Biol. Rep."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16300087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16300087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:31:48Z","timestamp":1759534308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X16300087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":89,"alternative-id":["S0300483X16300087"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2016.01.008","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral exposure to mineral oils: Is there an association with immune perturbation and autoimmunity?","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2016.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}